ADC – PROSTATE WARRIORS – The latest news about prostate cancer

Tag Archive for: ADC

Phase 1/2 Results for MHB088C Antibody-Drug Conjugate for mCRCP

May 23, 2025/0 Comments/in Clinical Trial, Metastatic, Phase 1, Phase 2/by Max

Trop-2: A Promising Therapeutic Target in Prostate Cancer

March 21, 2025/0 Comments/in Review/by Max

FG-3246 Advances to Phase 2 Trial in Prostate Cancer After Promising Early Results

March 6, 2025/0 Comments/in Clinical Trial, Metastatic, Phase 2/by Max

ASCO GU 2025: New Drug CBP-1018 Shows Promise for Advanced Prostate Cancer in Clinical Trial

February 14, 2025/0 Comments/in Clinical Trial, Metastatic, Phase 1, Phase 2/by Max

BR111: A New ADC Therapy That Could Work Also For Prostate Cancer

February 11, 2025/0 Comments/in Clinical Trial, Not PCa related/by Max

Phase 1 Trial: CRB-701, A Promising Antibody-Drug Conjugate Targeting Nectin-4

February 3, 2025/0 Comments/in Clinical Trial, Metastatic, Phase 1/by Max

LY4052031 and LY4101174: Other 2 Nectin-4-Targeting Therapy

February 3, 2025/0 Comments/in Clinical Trial, Metastatic, Phase 1/by Max

IPH4502 Phase 1 Clinical Trial for Solid Tumors Expressing Nectin-4

January 24, 2025/0 Comments/in Clinical Trial, Metastatic, Phase 1/by Max

Phase 1 Clinical Trial for ADRX-0405 in Advanced Solid Tumors Including Prostate Cancer

January 8, 2025/0 Comments/in Clinical Trial, Metastatic, Phase 1/by Max

B7-H4-Targeting Antibody-Drug Conjugate, LNCB74, Gets Green Light for Clinical Trials for Solid Tumors

December 11, 2024/0 Comments/in Clinical Trial, Phase 1/by Max